ReviewWorld journal of gastroenterology2021
Remaining issues of recommended management in current guidelines for asymptomatic common bile duct stones.
Review in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05592795 (Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Comparative Outcomes of Endoscopic Treatment for Symptomatic and Asymptomatic Common Bile Duct Stones in the Elderly: A Propensity Score-Based Cohort Analysis.Journal of hepato-biliary-pancreatic sciences · 2026Article
- Postoperative ERCP as proxy for clinically significant retained stones in a population-based cohort?Surgery open science · 2026Article
- The application value of preoperative magnetic resonance cholangiopancreatography in predicting the success of endoscopic retrograde cholangiopancreatography stone removal.Frontiers in medicine · 2026Article
- Risk Factors and Predictive Modeling of Occult Choledocholithiasis in Patients with Cholecystolithiasis.Gastroenterology research and practice · 2026Article
- Textbook outcome and associated risk factors in laparoscopic transcystic common bile duct exploration.World journal of gastroenterology · 2025Article
- Feasibility of cholecystectomy in patients with silent common bile duct stones cohort prospective single arm multicentre study.BMC gastroenterology · 2025Observational
- Endoscopic nasobiliary drainage is superior to biliary stent placement in preventing postendoscopic papillary balloon dilation pancreatitis.Therapeutic advances in gastroenterology · 2025Article
- Review
- Management of intraoperatively identified small bile duct stones in patients undergoing cholecystectomy.Langenbeck's archives of surgery · 2024Article
- Risk factors for post‑retrograde cholangiopancreatography pancreatitis in patients with common bile duct stones: A meta‑analysis.Experimental and therapeutic medicine · 2024Article
- Current management of concomitant cholelithiasis and common bile duct stones.World journal of gastrointestinal surgery · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current guidelines for treating asymptomatic common bile duct stones (CBDS) recommend stone removal, with endoscopic retrograde cholangiopancreatography (ERCP) being the first treatment choice. When deciding on ERCP treatment for asymptomatic CBDS, the risk of ERCP-related complications and outcome of natural history of asymptomatic CBDS should be compared. The incidence rate of ERCP-related complications, particularly of post-ERCP pancreatitis for asymptomatic CBDS, was reportedly higher than that of symptomatic CBDS, increasing the risk of ERCP-related complications for asymptomatic CBDS compared with that previously reported for biliopancreatic diseases. Although studies have reported short- to middle-term outcomes of natural history of asymptomatic CBDS, its long-term natural history is not well known. Till date, there are no prospective studies that determined whether ERCP has a better outcome than no treatment in patients with asymptomatic CBDS or not. No randomized controlled trial has evaluated the risk of early and late ERCP-related complications
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.